Delivery Order SPE2DB20D3505-SPE2DB25FYCPE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) with a ceiling value of $1,148.28. This is a firm fixed-price, non-set-aside contract utilizing a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL, a combination antibiotic-corticosteroid medication used to treat ear infections. This firm fixed-price delivery order has a ceiling value of $3,138.24 and is scheduled for completion by July 15, 2025. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml with a ceiling value of $2,177.06. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. The contract is scheduled for ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,666.01 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) with a ceiling value of $17,136.44. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 26, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic-corticosteroid medication used to treat ear infections. This firm fixed price delivery order has a ceiling value of $3,138.24 and is scheduled for completion by July 28, 2025. The award was made competitively without a set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.90 to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with performance completion scheduled for June 4, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL, valued at $3,876.32. This firm fixed-price delivery order, which is not a set-aside contract, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a delivery order contract valued at $2,288.30 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and anti-inflammatory medication used for ear infections. This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, which serves...
- The Defense Logistics Agency awarded a $2,229.61 delivery order to AmerisourceBergen Drug Corp for ciprofloxacin-dexamethasone otic suspension (7.5mL) on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The delivery...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCPEDelivery Order
The Defense Logistics Agency awarded a $1,139.94 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL). This firm fixed-price contract, which is not set-aside designated, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. As a critical vendor for the DLA Medical Supply Chain, the company maintains an extensive portfolio of pharmaceutical products spanning multiple therapeutic domains, including antibiotics, specialty medications, vaccines, and medical devices. The September 2025 delivery order for the otic antibiotic-corticosteroid suspension is consistent with AmerisourceBergen's role in supplying essential medications to support military healthcare programs and other government healthcare systems worldwide. The contract has a completion date of September 18, 2025, reflecting the expedited delivery requirements typical of medical supply procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/17/25 |